Safety profile and clinical activity of sifalimumab, a fully human anti-interferon monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study
Merrill, J. T., Wallace, D. J., Petri, M., Kirou, K. A., Yao, Y., White, W. I., Robbie, G., Levin, R., Berney, S. M., Chindalore, V., Olsen, N., Richman, L., Le, C., Jallal, B., White, B.Volume:
70
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/ard.2010.144485
Date:
November, 2011
File:
PDF, 385 KB
english, 2011